PRESS RELEASE published on 08/14/2024 at 07:30, 2 years ago Sustained organic growth in high-margin existing branded pharmaceutical business Dermapharm Holding SE reports sustained organic growth in high-margin existing branded pharmaceutical business, with year-on-year drop in revenue and EBITDA in first half of 2024 Financial Results 2024 Outlook Organic Growth Dermapharm Holding SE Branded Pharmaceuticals
BRIEF published on 06/27/2024 at 18:20, 2 years 1 month ago Dermapharm Holding SE : l'Assemblée générale annuelle décide de distribuer un dividende de 0,88 EUR par action Dividende Assemblée Générale Annuelle Perspectives Financières Dermapharm
BRIEF published on 06/27/2024 at 18:20, 2 years 1 month ago Dermapharm Holding SE: Annual General Meeting Resolves Dividend Distribution of EUR 0.88 Per Share Annual General Meeting Dividend Financial Outlook Dermapharm
PRESS RELEASE published on 06/27/2024 at 18:15, 2 years 1 month ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share Dermapharm Holding SE's Annual General Meeting approves EUR 0.88 per share dividend distribution for 2024. Board actions confirmed. Outlook and acquisitions strategies highlighted Annual General Meeting Acquisitions Outlook Dividend Distribution Dermapharm Holding SE
BRIEF published on 05/15/2024 at 07:35, 2 years 2 months ago Dermapharm Holding SE annonce une baisse de son chiffre d'affaires au premier trimestre 2024 dans un contexte de forte croissance des produits pharmaceutiques de marque Résultats Financiers Croissance Organique Résilience Du Marché Produits De Santé Produits Pharmaceutiques De Marque
BRIEF published on 05/15/2024 at 07:35, 2 years 2 months ago Dermapharm Holding SE Reports Decline in Q1 2024 Revenue Amidst Strong Branded Pharmaceuticals Growth Financial Results Organic Growth Market Resilience Healthcare Products Branded Pharmaceuticals
PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 2 months ago Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy Dermapharm Holding SE reports strong organic growth in core markets with resilient corporate strategy in Q1 2024 Organic Growth Q1 2024 Core Markets Dermapharm Holding SE Resilient Strategy
BRIEF published on 03/28/2024 at 07:35, 2 years 4 months ago Dermapharm Holding SE répond à toutes les attentes dans un contexte économique difficile Rapport Annuel 2023 Défis Économiques Dermapharm Holding SE Industrie Pharmaceutique Attentes De Croissance
BRIEF published on 03/28/2024 at 07:35, 2 years 4 months ago Dermapharm Holding SE Meets All Expectations in Challenging Economic Climate Pharmaceutical Industry Annual Report 2023 Economic Challenges Dermapharm Holding SE Growth Expectations
PRESS RELEASE published on 03/28/2024 at 07:30, 2 years 4 months ago Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges Dermapharm Holding SE fulfils all expectations in 2023 despite macroeconomic challenges, with revenue up by 10.8% to EUR 1,135.4 million and adjusted EBITDA margin at 27.3% Pharmaceutical Industry Revenue Growth EBITDA Margin Annual Report Dermapharm Holding SE
Published on 08/15/2026 at 00:50, 3 hours 31 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 4 hours 6 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 4 hours 36 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 4 hours 56 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 5 hours 21 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 10 hours 6 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 12 hours 16 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 12 hours 52 minutes ago Tradegate AG publishes its half-year report
Published on 08/13/2026 at 18:00, 1 day 10 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 10 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 10 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 10 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 10 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
